Article Text
Editorial
To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation
Statistics from Altmetric.com
Footnotes
Competing interests GYHL has served as a consultant for Bayer/Janssen, BMS/Pfizer, Biotronik, Medtronic, Boehringer Ingelheim, Microlife and Daiichi-Sankyo. Speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Microlife, Roche and Daiichi-Sankyo.
Provenance and peer review Commissioned; internally peer reviewed.